

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.28659503 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.28659503 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.94395311 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.94395311 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.56139323 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.20714464 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.91458234 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.91458234 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.91458234 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.77875504 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.77076115 |
| 12 | water-soluble vitamin biosynthetic process (GO:0042364) | 5.74671884 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.59656255 |
| 14 | urea metabolic process (GO:0019627) | 5.57284738 |
| 15 | urea cycle (GO:0000050) | 5.57284738 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.56517179 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.54985817 |
| 18 | cysteine metabolic process (GO:0006534) | 5.43110288 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.32331031 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.21372526 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.19385516 |
| 22 | complement activation, alternative pathway (GO:0006957) | 5.15543214 |
| 23 | nitrogen cycle metabolic process (GO:0071941) | 5.11826733 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.11177545 |
| 25 | protein carboxylation (GO:0018214) | 5.07724551 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.07724551 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.02254406 |
| 28 | bile acid metabolic process (GO:0008206) | 5.02128861 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.97094451 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.95621364 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.92732731 |
| 32 | epithelial cell fate commitment (GO:0072148) | 4.80612789 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 4.80188898 |
| 34 | regulation of complement activation (GO:0030449) | 4.78860568 |
| 35 | regulation of cholesterol esterification (GO:0010872) | 4.77188887 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.77172583 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.76289011 |
| 38 | lysine catabolic process (GO:0006554) | 4.73299146 |
| 39 | lysine metabolic process (GO:0006553) | 4.73299146 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.63112091 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.63112091 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.63112091 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.59439402 |
| 44 | phospholipid efflux (GO:0033700) | 4.56300389 |
| 45 | bile acid and bile salt transport (GO:0015721) | 4.55492278 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.55327100 |
| 47 | negative regulation of sterol transport (GO:0032372) | 4.49514226 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 4.49514226 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.48966208 |
| 50 | dopamine transport (GO:0015872) | 4.37081024 |
| 51 | * triglyceride homeostasis (GO:0070328) | 4.30494225 |
| 52 | * acylglycerol homeostasis (GO:0055090) | 4.30494225 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 4.30222924 |
| 54 | drug catabolic process (GO:0042737) | 4.29443929 |
| 55 | cellular glucuronidation (GO:0052695) | 4.29076631 |
| 56 | cholesterol efflux (GO:0033344) | 4.26542042 |
| 57 | indolalkylamine metabolic process (GO:0006586) | 4.23324829 |
| 58 | intestinal cholesterol absorption (GO:0030299) | 4.22761826 |
| 59 | glycine metabolic process (GO:0006544) | 4.20992870 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 4.20442323 |
| 61 | coenzyme catabolic process (GO:0009109) | 4.19630080 |
| 62 | glutamate metabolic process (GO:0006536) | 4.16672411 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 4.16555793 |
| 64 | regulation of bile acid biosynthetic process (GO:0070857) | 4.12448173 |
| 65 | serine family amino acid metabolic process (GO:0009069) | 4.11682482 |
| 66 | plasma lipoprotein particle assembly (GO:0034377) | 4.09308159 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 4.06106510 |
| 68 | amine catabolic process (GO:0009310) | 4.06106510 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 4.04852898 |
| 70 | imidazole-containing compound metabolic process (GO:0052803) | 4.02713097 |
| 71 | astrocyte differentiation (GO:0048708) | 4.01717013 |
| 72 | benzene-containing compound metabolic process (GO:0042537) | 3.99596363 |
| 73 | ethanol oxidation (GO:0006069) | 3.98029931 |
| 74 | serine family amino acid biosynthetic process (GO:0009070) | 3.91017338 |
| 75 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.87771215 |
| 76 | regulation of cholesterol homeostasis (GO:2000188) | 3.87691377 |
| 77 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.85276815 |
| 78 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.85276815 |
| 79 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.84222098 |
| 80 | phospholipid homeostasis (GO:0055091) | 3.83814201 |
| 81 | low-density lipoprotein particle remodeling (GO:0034374) | 3.83643710 |
| 82 | glucuronate metabolic process (GO:0019585) | 3.82017720 |
| 83 | uronic acid metabolic process (GO:0006063) | 3.82017720 |
| 84 | arginine metabolic process (GO:0006525) | 3.79720176 |
| 85 | * cholesterol homeostasis (GO:0042632) | 3.76571705 |
| 86 | endocrine pancreas development (GO:0031018) | 3.76348982 |
| 87 | drug transmembrane transport (GO:0006855) | 3.75616619 |
| 88 | fibrinolysis (GO:0042730) | 3.74918980 |
| 89 | insulin secretion (GO:0030073) | 3.73587110 |
| 90 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.73021946 |
| 91 | positive regulation of lipid catabolic process (GO:0050996) | 3.72896230 |
| 92 | ketone body metabolic process (GO:1902224) | 3.71696848 |
| 93 | * sterol homeostasis (GO:0055092) | 3.71306544 |
| 94 | aldehyde catabolic process (GO:0046185) | 3.71254618 |
| 95 | protein-lipid complex assembly (GO:0065005) | 3.69770901 |
| 96 | short-chain fatty acid metabolic process (GO:0046459) | 3.68691898 |
| 97 | organic acid catabolic process (GO:0016054) | 3.67982638 |
| 98 | carboxylic acid catabolic process (GO:0046395) | 3.67982638 |
| 99 | flavonoid metabolic process (GO:0009812) | 3.67259376 |
| 100 | lipoprotein metabolic process (GO:0042157) | 3.65519735 |
| 101 | acetyl-CoA metabolic process (GO:0006084) | 3.62710070 |
| 102 | plasma lipoprotein particle organization (GO:0071827) | 3.57428185 |
| 103 | complement activation, classical pathway (GO:0006958) | 3.56258490 |
| 104 | urate metabolic process (GO:0046415) | 3.55649578 |
| 105 | lactate metabolic process (GO:0006089) | 3.55205507 |
| 106 | cofactor catabolic process (GO:0051187) | 3.55202262 |
| 107 | complement activation (GO:0006956) | 3.52834260 |
| 108 | blood coagulation, intrinsic pathway (GO:0007597) | 3.52829638 |
| 109 | regulation of glucokinase activity (GO:0033131) | 3.50087565 |
| 110 | regulation of hexokinase activity (GO:1903299) | 3.50087565 |
| 111 | alanine transport (GO:0032328) | 3.49172013 |
| 112 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.48883025 |
| 113 | glycerophospholipid catabolic process (GO:0046475) | 3.47408893 |
| 114 | inositol phosphate catabolic process (GO:0071545) | 3.46805671 |
| 115 | ubiquinone metabolic process (GO:0006743) | 3.40088744 |
| 116 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.36866161 |
| 117 | early endosome to late endosome transport (GO:0045022) | 3.36840440 |
| 118 | catecholamine transport (GO:0051937) | 3.34874056 |
| 119 | auditory receptor cell differentiation (GO:0042491) | 3.34209245 |
| 120 | regulation of acrosome reaction (GO:0060046) | 3.32860888 |
| 121 | L-ascorbic acid metabolic process (GO:0019852) | 3.29602326 |
| 122 | peptide hormone processing (GO:0016486) | 3.26426728 |
| 123 | detection of light stimulus involved in visual perception (GO:0050908) | 3.25953172 |
| 124 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.25953172 |
| 125 | fucose catabolic process (GO:0019317) | 3.25682147 |
| 126 | L-fucose metabolic process (GO:0042354) | 3.25682147 |
| 127 | L-fucose catabolic process (GO:0042355) | 3.25682147 |
| 128 | proline transport (GO:0015824) | 3.23156491 |
| 129 | positive regulation of insulin secretion (GO:0032024) | 3.20329420 |
| 130 | inositol phosphate dephosphorylation (GO:0046855) | 3.17341167 |
| 131 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.17341167 |
| 132 | estrogen biosynthetic process (GO:0006703) | 3.12667908 |
| 133 | protein-chromophore linkage (GO:0018298) | 3.11103102 |
| 134 | kidney morphogenesis (GO:0060993) | 3.11095925 |
| 135 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.08842309 |
| 136 | signal peptide processing (GO:0006465) | 3.08505647 |
| 137 | toxin metabolic process (GO:0009404) | 3.08255806 |
| 138 | respiratory chain complex IV assembly (GO:0008535) | 3.07498523 |
| 139 | establishment of protein localization to Golgi (GO:0072600) | 3.06061584 |
| 140 | phenylpropanoid metabolic process (GO:0009698) | 3.04814009 |
| 141 | ubiquinone biosynthetic process (GO:0006744) | 3.04077302 |
| 142 | alkaloid metabolic process (GO:0009820) | 2.96692558 |
| 143 | protein targeting to Golgi (GO:0000042) | 2.93212433 |
| 144 | serotonin metabolic process (GO:0042428) | 2.89921101 |
| 145 | polyol catabolic process (GO:0046174) | 2.88744528 |
| 146 | vitamin biosynthetic process (GO:0009110) | 2.88373917 |
| 147 | positive regulation of peptide hormone secretion (GO:0090277) | 2.88124118 |
| 148 | primary amino compound metabolic process (GO:1901160) | 2.85396621 |
| 149 | cytochrome complex assembly (GO:0017004) | 2.80144529 |
| 150 | quinone biosynthetic process (GO:1901663) | 2.78696874 |
| 151 | xenobiotic catabolic process (GO:0042178) | 2.77344709 |
| 152 | axoneme assembly (GO:0035082) | 2.76478974 |
| 153 | glandular epithelial cell differentiation (GO:0002067) | 2.75965838 |
| 154 | positive regulation of peptide secretion (GO:0002793) | 2.74406774 |
| 155 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.71957695 |
| 156 | protein localization to Golgi apparatus (GO:0034067) | 2.70089024 |
| 157 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.67761414 |
| 158 | nitric oxide mediated signal transduction (GO:0007263) | 2.67616273 |
| 159 | organic cation transport (GO:0015695) | 2.67573993 |
| 160 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.66212092 |
| 161 | nephron tubule morphogenesis (GO:0072078) | 2.66147662 |
| 162 | nephron epithelium morphogenesis (GO:0072088) | 2.66147662 |
| 163 | positive regulation of meiosis (GO:0045836) | 2.65817275 |
| 164 | regulation of glucocorticoid secretion (GO:2000849) | 2.64694104 |
| 165 | response to corticosterone (GO:0051412) | 2.64338731 |
| 166 | behavioral response to nicotine (GO:0035095) | 2.63753247 |
| 167 | calcium ion import (GO:0070509) | 2.63720929 |
| 168 | dopamine biosynthetic process (GO:0042416) | 2.62829209 |
| 169 | positive regulation of gluconeogenesis (GO:0045722) | 2.60490608 |
| 170 | positive regulation of glycolytic process (GO:0045821) | 2.59519047 |
| 171 | dorsal/ventral axis specification (GO:0009950) | 2.57784969 |
| 172 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.57056365 |
| 173 | macroautophagy (GO:0016236) | 2.53333915 |
| 174 | nodal signaling pathway (GO:0038092) | 2.51078047 |
| 175 | phospholipid catabolic process (GO:0009395) | 2.49488744 |
| 176 | protein complex biogenesis (GO:0070271) | 2.48401372 |
| 177 | estrogen metabolic process (GO:0008210) | 2.48090991 |
| 178 | positive regulation of meiotic cell cycle (GO:0051446) | 2.47624329 |
| 179 | regulation of neurotransmitter uptake (GO:0051580) | 2.46579434 |
| 180 | exogenous drug catabolic process (GO:0042738) | 2.46200947 |
| 181 | detection of calcium ion (GO:0005513) | 2.42270440 |
| 182 | indole-containing compound metabolic process (GO:0042430) | 2.41022332 |
| 183 | peptide hormone secretion (GO:0030072) | 2.38785442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.20057271 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.06262492 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.76759079 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.45463997 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.11521209 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.83747746 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.51139182 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.07123912 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.80001058 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.67869528 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.57691672 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.37940479 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.32054622 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.26221775 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.20745070 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.16761371 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04982554 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5069663 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.98592568 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91274886 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.90124483 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 1.88649879 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 1.88415857 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.83581200 |
| 25 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.81525873 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76516953 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.74406069 |
| 28 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.74160288 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.74140641 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.68707048 |
| 31 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.66284792 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66251283 |
| 33 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.62021481 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.60759248 |
| 35 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.56199762 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51866628 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.51684705 |
| 38 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.50772455 |
| 39 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.49013769 |
| 40 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.48669854 |
| 41 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.47032174 |
| 42 | STAT3_23295773_ChIP-Seq_U87_Human | 1.46274664 |
| 43 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44344350 |
| 44 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.43456452 |
| 45 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43434559 |
| 46 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.38477489 |
| 47 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.38477489 |
| 48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.36016442 |
| 49 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.35767862 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35265396 |
| 51 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.34726676 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34635709 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33773164 |
| 54 | TCF4_23295773_ChIP-Seq_U87_Human | 1.33366733 |
| 55 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.33308403 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33266779 |
| 57 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.32337833 |
| 58 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.31637028 |
| 59 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.31637028 |
| 60 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.31097579 |
| 61 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.31097579 |
| 62 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.30245267 |
| 63 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.30205945 |
| 64 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.29955014 |
| 65 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.28779693 |
| 66 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.27910468 |
| 67 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.27392080 |
| 68 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.26743939 |
| 69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26401144 |
| 70 | EWS_26573619_Chip-Seq_HEK293_Human | 1.26345557 |
| 71 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.25181429 |
| 72 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.25070168 |
| 73 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.21091811 |
| 74 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.19895371 |
| 75 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19158607 |
| 76 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.18186930 |
| 77 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16984240 |
| 78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16659386 |
| 79 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.15944943 |
| 80 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.15045849 |
| 81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14086705 |
| 82 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.13844459 |
| 83 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12584950 |
| 84 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12482245 |
| 85 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11988555 |
| 86 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.11579396 |
| 87 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.11486331 |
| 88 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.11275612 |
| 89 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11198178 |
| 90 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11093989 |
| 91 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10879068 |
| 92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09574239 |
| 93 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.08897104 |
| 94 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08339019 |
| 95 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07833388 |
| 96 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07627319 |
| 97 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.07604120 |
| 98 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.07071082 |
| 99 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07004915 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05220361 |
| 101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04592567 |
| 102 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04483238 |
| 103 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02202598 |
| 104 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02049636 |
| 105 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01966744 |
| 106 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.01843261 |
| 107 | NCOR_22424771_ChIP-Seq_293T_Human | 1.01652459 |
| 108 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.01558285 |
| 109 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.99608513 |
| 110 | NFYB_21822215_ChIP-Seq_K562_Human | 0.99539328 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97356655 |
| 112 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91696004 |
| 113 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89049906 |
| 114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87194220 |
| 115 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.86312693 |
| 116 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86225564 |
| 117 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85841795 |
| 118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85638535 |
| 119 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82987600 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82092780 |
| 121 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81633588 |
| 122 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.77842225 |
| 123 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76129458 |
| 124 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76039142 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74357100 |
| 126 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73850399 |
| 127 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73588274 |
| 128 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72322363 |
| 129 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.71969187 |
| 130 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71071992 |
| 131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71071992 |
| 132 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70849659 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.70676985 |
| 134 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70380907 |
| 135 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70363181 |
| 136 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.70254743 |
| 137 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69265157 |
| 138 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.66328429 |
| 139 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.65914048 |
| 140 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.62129370 |
| 141 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61772622 |
| 142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60674915 |
| 143 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59348405 |
| 144 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59269603 |
| 145 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58693416 |
| 146 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.58672170 |
| 147 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57856988 |
| 148 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56943204 |
| 149 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.56856963 |
| 150 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55959051 |
| 151 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.54517751 |
| 152 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.54232518 |
| 153 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54086959 |
| 154 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.53265285 |
| 155 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52567443 |
| 156 | GATA2_19941826_ChIP-Seq_K562_Human | 0.51453705 |
| 157 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51369898 |
| 158 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51356680 |
| 159 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50252044 |
| 160 | GATA1_19941826_ChIP-Seq_K562_Human | 0.49877428 |
| 161 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.49481255 |
| 162 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48813877 |
| 163 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.48417917 |
| 164 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.47537327 |
| 165 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.46715085 |
| 166 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46329558 |
| 167 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.45437913 |
| 168 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.45163080 |
| 169 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44022804 |
| 170 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43130550 |
| 171 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.41805246 |
| 172 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41771612 |
| 173 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40659677 |
| 174 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.40422608 |
| 175 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.39723886 |
| 176 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.39001442 |
| 177 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38658349 |
| 178 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38482360 |
| 179 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.37432377 |
| 180 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.37366286 |
| 181 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.37255574 |
| 182 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.35814004 |
| 183 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.35774073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.15169185 |
| 2 | MP0005360_urolithiasis | 7.81134637 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.38512932 |
| 4 | MP0005365_abnormal_bile_salt | 6.10249011 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.03680691 |
| 6 | MP0003252_abnormal_bile_duct | 4.12400561 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.98432953 |
| 8 | MP0002638_abnormal_pupillary_reflex | 3.65757118 |
| 9 | MP0005379_endocrine/exocrine_gland_phen | 3.56453929 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.50506530 |
| 11 | MP0002909_abnormal_adrenal_gland | 3.50159608 |
| 12 | MP0009840_abnormal_foam_cell | 3.21495742 |
| 13 | MP0001666_abnormal_nutrient_absorption | 3.08430068 |
| 14 | MP0005083_abnormal_biliary_tract | 2.99320720 |
| 15 | MP0002163_abnormal_gland_morphology | 2.85460794 |
| 16 | MP0003195_calcinosis | 2.78441438 |
| 17 | MP0005332_abnormal_amino_acid | 2.76898071 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.76527729 |
| 19 | MP0009046_muscle_twitch | 2.62319417 |
| 20 | MP0005645_abnormal_hypothalamus_physiol | 2.58690691 |
| 21 | MP0003787_abnormal_imprinting | 2.35546404 |
| 22 | MP0002693_abnormal_pancreas_physiology | 2.35416100 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.32279802 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.12856267 |
| 25 | MP0000609_abnormal_liver_physiology | 2.11687412 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.08633064 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 2.06960484 |
| 28 | MP0008877_abnormal_DNA_methylation | 2.05442583 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.95997366 |
| 30 | MP0003868_abnormal_feces_composition | 1.95457812 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.94553769 |
| 32 | MP0005551_abnormal_eye_electrophysiolog | 1.86978578 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.83788555 |
| 34 | MP0006072_abnormal_retinal_apoptosis | 1.81111444 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.80271952 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.77223322 |
| 37 | MP0001502_abnormal_circadian_rhythm | 1.63081412 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.61968753 |
| 39 | MP0001764_abnormal_homeostasis | 1.60999749 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49106305 |
| 41 | MP0009697_abnormal_copulation | 1.48160770 |
| 42 | MP0000372_irregular_coat_pigmentation | 1.46236029 |
| 43 | MP0005253_abnormal_eye_physiology | 1.45961425 |
| 44 | MP0009745_abnormal_behavioral_response | 1.41061457 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.40887928 |
| 46 | MP0004885_abnormal_endolymph | 1.35481951 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.32983980 |
| 48 | MP0005451_abnormal_body_composition | 1.27218273 |
| 49 | MP0001905_abnormal_dopamine_level | 1.27169943 |
| 50 | MP0003122_maternal_imprinting | 1.27075896 |
| 51 | MP0002557_abnormal_social/conspecific_i | 1.26094890 |
| 52 | MP0004147_increased_porphyrin_level | 1.20020779 |
| 53 | MP0001984_abnormal_olfaction | 1.19756772 |
| 54 | MP0000598_abnormal_liver_morphology | 1.14234983 |
| 55 | MP0003186_abnormal_redox_activity | 1.13901252 |
| 56 | MP0003011_delayed_dark_adaptation | 1.13439747 |
| 57 | MP0002938_white_spotting | 1.13346286 |
| 58 | MP0002272_abnormal_nervous_system | 1.13208326 |
| 59 | MP0003705_abnormal_hypodermis_morpholog | 1.12821485 |
| 60 | MP0003283_abnormal_digestive_organ | 1.12408463 |
| 61 | MP0002064_seizures | 1.11400058 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.10494770 |
| 63 | MP0004270_analgesia | 1.09970493 |
| 64 | MP0003879_abnormal_hair_cell | 1.09114075 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.08583218 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.08210836 |
| 67 | MP0002572_abnormal_emotion/affect_behav | 1.07235552 |
| 68 | MP0003172_abnormal_lysosome_physiology | 1.07124604 |
| 69 | MP0002254_reproductive_system_inflammat | 1.06974931 |
| 70 | MP0004133_heterotaxia | 1.04554356 |
| 71 | MP0005174_abnormal_tail_pigmentation | 1.04132974 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 1.03108627 |
| 73 | MP0002229_neurodegeneration | 1.02123661 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 0.98783196 |
| 75 | MP0005647_abnormal_sex_gland | 0.97497664 |
| 76 | MP0001970_abnormal_pain_threshold | 0.97126147 |
| 77 | MP0002090_abnormal_vision | 0.97085329 |
| 78 | MP0009764_decreased_sensitivity_to | 0.96915867 |
| 79 | MP0000427_abnormal_hair_cycle | 0.96395431 |
| 80 | MP0008995_early_reproductive_senescence | 0.96114802 |
| 81 | MP0000604_amyloidosis | 0.96032212 |
| 82 | MP0000631_abnormal_neuroendocrine_gland | 0.94211096 |
| 83 | MP0005410_abnormal_fertilization | 0.93865796 |
| 84 | MP0002733_abnormal_thermal_nociception | 0.93844305 |
| 85 | MP0005386_behavior/neurological_phenoty | 0.93471346 |
| 86 | MP0004924_abnormal_behavior | 0.93471346 |
| 87 | MP0005220_abnormal_exocrine_pancreas | 0.93294133 |
| 88 | MP0009763_increased_sensitivity_to | 0.91615289 |
| 89 | MP0002736_abnormal_nociception_after | 0.91592535 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.90970689 |
| 91 | MP0004085_abnormal_heartbeat | 0.89136127 |
| 92 | MP0005408_hypopigmentation | 0.87517666 |
| 93 | MP0003633_abnormal_nervous_system | 0.87158443 |
| 94 | MP0009642_abnormal_blood_homeostasis | 0.87115882 |
| 95 | MP0002078_abnormal_glucose_homeostasis | 0.86112459 |
| 96 | MP0000003_abnormal_adipose_tissue | 0.85932522 |
| 97 | MP0002734_abnormal_mechanical_nocicepti | 0.85279394 |
| 98 | MP0008469_abnormal_protein_level | 0.83369743 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.82594806 |
| 100 | MP0000569_abnormal_digit_pigmentation | 0.80585736 |
| 101 | MP0010368_abnormal_lymphatic_system | 0.77840181 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.77451102 |
| 103 | MP0004142_abnormal_muscle_tone | 0.77427017 |
| 104 | MP0005376_homeostasis/metabolism_phenot | 0.75256600 |
| 105 | MP0006036_abnormal_mitochondrial_physio | 0.74585441 |
| 106 | MP0003121_genomic_imprinting | 0.73572999 |
| 107 | MP0001756_abnormal_urination | 0.72912330 |
| 108 | MP0005670_abnormal_white_adipose | 0.71538542 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.71238496 |
| 110 | MP0003045_fibrosis | 0.70603601 |
| 111 | MP0004264_abnormal_extraembryonic_tissu | 0.70348748 |
| 112 | MP0005334_abnormal_fat_pad | 0.68597489 |
| 113 | MP0002971_abnormal_brown_adipose | 0.67803277 |
| 114 | MP0005535_abnormal_body_temperature | 0.66292423 |
| 115 | MP0001661_extended_life_span | 0.66085917 |
| 116 | MP0005448_abnormal_energy_balance | 0.65757271 |
| 117 | MP0009053_abnormal_anal_canal | 0.65624528 |
| 118 | MP0004043_abnormal_pH_regulation | 0.64788130 |
| 119 | MP0005266_abnormal_metabolism | 0.62833737 |
| 120 | MP0002928_abnormal_bile_duct | 0.61151360 |
| 121 | MP0004130_abnormal_muscle_cell | 0.60597850 |
| 122 | MP0010234_abnormal_vibrissa_follicle | 0.59343976 |
| 123 | MP0002136_abnormal_kidney_physiology | 0.56989584 |
| 124 | MP0003329_amyloid_beta_deposits | 0.54926674 |
| 125 | MP0000639_abnormal_adrenal_gland | 0.54235202 |
| 126 | MP0002822_catalepsy | 0.52942080 |
| 127 | MP0003690_abnormal_glial_cell | 0.52694428 |
| 128 | MP0006035_abnormal_mitochondrial_morpho | 0.50243066 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.49629914 |
| 130 | MP0005395_other_phenotype | 0.46965159 |
| 131 | MP0003953_abnormal_hormone_level | 0.46834213 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.45097966 |
| 133 | MP0009384_cardiac_valve_regurgitation | 0.44427382 |
| 134 | MP0005464_abnormal_platelet_physiology | 0.44235938 |
| 135 | MP0003300_gastrointestinal_ulcer | 0.43556590 |
| 136 | MP0003718_maternal_effect | 0.43362237 |
| 137 | MP0005248_abnormal_Harderian_gland | 0.42384525 |
| 138 | MP0002796_impaired_skin_barrier | 0.41945245 |
| 139 | MP0008873_increased_physiological_sensi | 0.41112097 |
| 140 | MP0005666_abnormal_adipose_tissue | 0.40172675 |
| 141 | MP0000579_abnormal_nail_morphology | 0.39692613 |
| 142 | MP0001765_abnormal_ion_homeostasis | 0.38489529 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.37279494 |
| 144 | MP0001944_abnormal_pancreas_morphology | 0.36809167 |
| 145 | MP0009672_abnormal_birth_weight | 0.36192181 |
| 146 | MP0005166_decreased_susceptibility_to | 0.35908582 |
| 147 | MP0000538_abnormal_urinary_bladder | 0.35705989 |
| 148 | MP0008874_decreased_physiological_sensi | 0.33983674 |
| 149 | MP0008872_abnormal_physiological_respon | 0.33094344 |
| 150 | MP0005058_abnormal_lysosome_morphology | 0.32912535 |
| 151 | MP0002168_other_aberrant_phenotype | 0.32473205 |
| 152 | MP0002837_dystrophic_cardiac_calcinosis | 0.32417625 |
| 153 | MP0003724_increased_susceptibility_to | 0.31657603 |
| 154 | MP0001881_abnormal_mammary_gland | 0.30984381 |
| 155 | MP0009115_abnormal_fat_cell | 0.30619669 |
| 156 | MP0003436_decreased_susceptibility_to | 0.30573213 |
| 157 | MP0003075_altered_response_to | 0.30114621 |
| 158 | MP0000249_abnormal_blood_vessel | 0.27823627 |
| 159 | MP0001845_abnormal_inflammatory_respons | 0.27467140 |
| 160 | MP0002970_abnormal_white_adipose | 0.27024874 |
| 161 | MP0002060_abnormal_skin_morphology | 0.26922847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.34275384 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.03210755 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.90913375 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.56039897 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.51145623 |
| 6 | Xanthomatosis (HP:0000991) | 6.19901596 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 6.15513761 |
| 8 | Complement deficiency (HP:0004431) | 5.12830063 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.00617488 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.77660357 |
| 11 | Epidermoid cyst (HP:0200040) | 4.59890859 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.57568953 |
| 13 | Hyperammonemia (HP:0001987) | 4.50687048 |
| 14 | Fat malabsorption (HP:0002630) | 4.43168863 |
| 15 | Joint hemorrhage (HP:0005261) | 4.40789199 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.39180672 |
| 17 | Hyperglycinemia (HP:0002154) | 4.35410430 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.32413121 |
| 19 | Conjugated hyperbilirubinemia (HP:0002908) | 4.29504939 |
| 20 | Ketosis (HP:0001946) | 4.25754146 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.17182916 |
| 22 | Hypothermia (HP:0002045) | 4.16667804 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.09663788 |
| 24 | Hyperglycinuria (HP:0003108) | 4.09548588 |
| 25 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.08021030 |
| 26 | Hypoglycemic coma (HP:0001325) | 4.07046276 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.99108335 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.99108335 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.92900900 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 3.92039614 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.75692549 |
| 32 | Hypoplasia of the fovea (HP:0007750) | 3.71658805 |
| 33 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.71658805 |
| 34 | Abnormality of complement system (HP:0005339) | 3.71531204 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.63804013 |
| 36 | Hyperventilation (HP:0002883) | 3.63099800 |
| 37 | Congenital stationary night blindness (HP:0007642) | 3.62407876 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.59324403 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.35619430 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32704538 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.30379487 |
| 42 | Limb dystonia (HP:0002451) | 3.27802621 |
| 43 | Ketoacidosis (HP:0001993) | 3.24908326 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.20251785 |
| 45 | Acanthocytosis (HP:0001927) | 3.13892983 |
| 46 | Steatorrhea (HP:0002570) | 3.08485986 |
| 47 | Mesangial abnormality (HP:0001966) | 3.07360450 |
| 48 | Abnormality of the renal cortex (HP:0011035) | 3.03102941 |
| 49 | Delayed CNS myelination (HP:0002188) | 3.02139950 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 3.00715476 |
| 51 | Abnormality of the fovea (HP:0000493) | 2.93371224 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.92338760 |
| 53 | Abnormality of serum amino acid levels (HP:0003112) | 2.91186883 |
| 54 | Skin nodule (HP:0200036) | 2.89749301 |
| 55 | Attenuation of retinal blood vessels (HP:0007843) | 2.87373730 |
| 56 | Myocardial infarction (HP:0001658) | 2.82798933 |
| 57 | Metabolic acidosis (HP:0001942) | 2.82132796 |
| 58 | Gout (HP:0001997) | 2.80904652 |
| 59 | Hypoglycemic seizures (HP:0002173) | 2.80368030 |
| 60 | Severe visual impairment (HP:0001141) | 2.79896795 |
| 61 | Spontaneous abortion (HP:0005268) | 2.77608855 |
| 62 | Hypochromic microcytic anemia (HP:0004840) | 2.73667434 |
| 63 | Hypomagnesemia (HP:0002917) | 2.71603475 |
| 64 | Diastasis recti (HP:0001540) | 2.69934068 |
| 65 | Albinism (HP:0001022) | 2.62988425 |
| 66 | Nephronophthisis (HP:0000090) | 2.60482785 |
| 67 | Congenital sensorineural hearing impairment (HP:0008527) | 2.60081144 |
| 68 | Double outlet right ventricle (HP:0001719) | 2.58589182 |
| 69 | Congenital malformation of the right heart (HP:0011723) | 2.58589182 |
| 70 | Systemic lupus erythematosus (HP:0002725) | 2.58532291 |
| 71 | Malnutrition (HP:0004395) | 2.58432292 |
| 72 | Vascular calcification (HP:0004934) | 2.55625096 |
| 73 | Lethargy (HP:0001254) | 2.54875946 |
| 74 | Intestinal atresia (HP:0011100) | 2.54030128 |
| 75 | Medial flaring of the eyebrow (HP:0010747) | 2.53539681 |
| 76 | Pancreatic fibrosis (HP:0100732) | 2.53150581 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.52104362 |
| 78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.52104362 |
| 79 | Hemiparesis (HP:0001269) | 2.49581337 |
| 80 | Pancreatic cysts (HP:0001737) | 2.45273503 |
| 81 | Abnormality of midbrain morphology (HP:0002418) | 2.41184235 |
| 82 | Molar tooth sign on MRI (HP:0002419) | 2.41184235 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.41092525 |
| 84 | Agitation (HP:0000713) | 2.39729787 |
| 85 | Gaze-evoked nystagmus (HP:0000640) | 2.39522533 |
| 86 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.39164628 |
| 87 | Abnormality of macular pigmentation (HP:0008002) | 2.39014061 |
| 88 | Large for gestational age (HP:0001520) | 2.38770696 |
| 89 | Spastic diplegia (HP:0001264) | 2.38361187 |
| 90 | Abnormality of vitamin B metabolism (HP:0004340) | 2.37090979 |
| 91 | Progressive macrocephaly (HP:0004481) | 2.36792445 |
| 92 | Irritability (HP:0000737) | 2.36650997 |
| 93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.35931740 |
| 94 | Late onset (HP:0003584) | 2.34216308 |
| 95 | Microretrognathia (HP:0000308) | 2.33676652 |
| 96 | Cholecystitis (HP:0001082) | 2.33633110 |
| 97 | Abnormal gallbladder physiology (HP:0012438) | 2.33633110 |
| 98 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.32520603 |
| 99 | Glomerulonephritis (HP:0000099) | 2.31876796 |
| 100 | Cholelithiasis (HP:0001081) | 2.30916080 |
| 101 | Abnormality of the renal medulla (HP:0100957) | 2.30855027 |
| 102 | Tubular atrophy (HP:0000092) | 2.29219874 |
| 103 | Esophageal varix (HP:0002040) | 2.29154536 |
| 104 | Hydroxyprolinuria (HP:0003080) | 2.26209780 |
| 105 | Abnormality of proline metabolism (HP:0010907) | 2.26209780 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 2.25795365 |
| 107 | Cardiovascular calcification (HP:0011915) | 2.25616279 |
| 108 | Generalized aminoaciduria (HP:0002909) | 2.24148640 |
| 109 | Cerebral edema (HP:0002181) | 2.23740639 |
| 110 | Poikilocytosis (HP:0004447) | 2.21740821 |
| 111 | Pancreatitis (HP:0001733) | 2.21106775 |
| 112 | Mitral stenosis (HP:0001718) | 2.20839010 |
| 113 | Acute necrotizing encephalopathy (HP:0006965) | 2.17725241 |
| 114 | Neonatal onset (HP:0003623) | 2.17678294 |
| 115 | Abnormality of magnesium homeostasis (HP:0004921) | 2.17236235 |
| 116 | Enlarged kidneys (HP:0000105) | 2.14983419 |
| 117 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.14187178 |
| 118 | Polydipsia (HP:0001959) | 2.12822015 |
| 119 | Abnormal drinking behavior (HP:0030082) | 2.12822015 |
| 120 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.12094193 |
| 121 | Decreased circulating renin level (HP:0003351) | 2.10519718 |
| 122 | Mitochondrial inheritance (HP:0001427) | 2.06971661 |
| 123 | Limb hypertonia (HP:0002509) | 2.06716550 |
| 124 | Hepatic necrosis (HP:0002605) | 2.05154421 |
| 125 | Muscular hypotonia of the trunk (HP:0008936) | 2.05100522 |
| 126 | EEG with generalized epileptiform discharges (HP:0011198) | 2.04898470 |
| 127 | Amyloidosis (HP:0011034) | 2.04770304 |
| 128 | Menorrhagia (HP:0000132) | 2.04146935 |
| 129 | Increased CSF protein (HP:0002922) | 2.04093859 |
| 130 | Large eyes (HP:0001090) | 2.03040392 |
| 131 | Vomiting (HP:0002013) | 2.02751612 |
| 132 | Brushfield spots (HP:0001088) | 2.02536971 |
| 133 | Gingival bleeding (HP:0000225) | 2.02274025 |
| 134 | Glycosuria (HP:0003076) | 2.02029057 |
| 135 | Abnormality of urine glucose concentration (HP:0011016) | 2.02029057 |
| 136 | Rickets (HP:0002748) | 2.01769277 |
| 137 | True hermaphroditism (HP:0010459) | 2.01155753 |
| 138 | Hyperglycemia (HP:0003074) | 2.01148443 |
| 139 | Symptomatic seizures (HP:0011145) | 2.01136653 |
| 140 | Hypsarrhythmia (HP:0002521) | 2.00804399 |
| 141 | Type II lissencephaly (HP:0007260) | 2.00228959 |
| 142 | Alkalosis (HP:0001948) | 2.00218655 |
| 143 | Acute encephalopathy (HP:0006846) | 1.98896943 |
| 144 | Increased CSF lactate (HP:0002490) | 1.98245034 |
| 145 | Proximal tubulopathy (HP:0000114) | 1.97238161 |
| 146 | Epileptiform EEG discharges (HP:0011182) | 1.96734922 |
| 147 | Abnormality of the gallbladder (HP:0005264) | 1.96437933 |
| 148 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96325783 |
| 149 | Abolished electroretinogram (ERG) (HP:0000550) | 1.96163150 |
| 150 | Nephrogenic diabetes insipidus (HP:0009806) | 1.95620014 |
| 151 | Metabolic alkalosis (HP:0200114) | 1.94823434 |
| 152 | Increased purine levels (HP:0004368) | 1.94672074 |
| 153 | Hyperuricemia (HP:0002149) | 1.94672074 |
| 154 | Abnormality of vitamin metabolism (HP:0100508) | 1.93209151 |
| 155 | Opisthotonus (HP:0002179) | 1.90130625 |
| 156 | Prominent supraorbital ridges (HP:0000336) | 1.88515428 |
| 157 | Abnormal cartilage morphology (HP:0002763) | 1.87950588 |
| 158 | Hemorrhage of the eye (HP:0011885) | 1.87795529 |
| 159 | Thrombophlebitis (HP:0004418) | 1.87508475 |
| 160 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.87446821 |
| 161 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.87446821 |
| 162 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.86675312 |
| 163 | Distal arthrogryposis (HP:0005684) | 1.85794868 |
| 164 | Renal cortical cysts (HP:0000803) | 1.84542236 |
| 165 | Abnormal pupillary function (HP:0007686) | 1.84405937 |
| 166 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.83973993 |
| 167 | Congenital primary aphakia (HP:0007707) | 1.83734841 |
| 168 | 3-Methylglutaconic aciduria (HP:0003535) | 1.82494418 |
| 169 | Arthropathy (HP:0003040) | 1.81755566 |
| 170 | Gait imbalance (HP:0002141) | 1.79085523 |
| 171 | Nephrotic syndrome (HP:0000100) | 1.77804746 |
| 172 | Polyuria (HP:0000103) | 1.77733139 |
| 173 | Decreased central vision (HP:0007663) | 1.76889482 |
| 174 | Lipid accumulation in hepatocytes (HP:0006561) | 1.76855979 |
| 175 | Exocrine pancreatic insufficiency (HP:0001738) | 1.75412226 |
| 176 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.74258919 |
| 177 | Protuberant abdomen (HP:0001538) | 1.72914079 |
| 178 | Furrowed tongue (HP:0000221) | 1.71854477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.23897260 |
| 2 | ERN1 | 4.28582874 |
| 3 | FGFR4 | 4.09359497 |
| 4 | SIK1 | 4.09292022 |
| 5 | INSRR | 3.68468778 |
| 6 | TAOK3 | 3.62972404 |
| 7 | FRK | 3.03646415 |
| 8 | ERBB4 | 2.91028610 |
| 9 | MST1R | 2.74000160 |
| 10 | CSNK1G3 | 2.56220913 |
| 11 | MST4 | 2.29430143 |
| 12 | ADRBK2 | 2.28396000 |
| 13 | CSNK1G2 | 2.24640604 |
| 14 | PHKG1 | 2.23794839 |
| 15 | PHKG2 | 2.23794839 |
| 16 | MAP4K2 | 2.11455575 |
| 17 | LATS1 | 2.11327138 |
| 18 | PIK3CG | 1.95246503 |
| 19 | ACVR1B | 1.95017678 |
| 20 | MAP2K4 | 1.94866990 |
| 21 | NTRK3 | 1.94577557 |
| 22 | PKN2 | 1.93577315 |
| 23 | FLT3 | 1.92334390 |
| 24 | MAPK11 | 1.82534409 |
| 25 | CASK | 1.81161707 |
| 26 | MAP3K12 | 1.80618596 |
| 27 | MAP3K4 | 1.76159050 |
| 28 | PTK6 | 1.74907275 |
| 29 | TRIB3 | 1.49510524 |
| 30 | TYK2 | 1.44920694 |
| 31 | PDK2 | 1.41935033 |
| 32 | NEK9 | 1.39927903 |
| 33 | MAP3K10 | 1.36021184 |
| 34 | MAPK15 | 1.25808094 |
| 35 | ZAK | 1.25317274 |
| 36 | MET | 1.25227772 |
| 37 | FGFR2 | 1.24725739 |
| 38 | MAP3K7 | 1.24454240 |
| 39 | ABL2 | 1.24082236 |
| 40 | GRK6 | 1.23979724 |
| 41 | RIPK1 | 1.22876751 |
| 42 | PRKAA2 | 1.21613728 |
| 43 | PRKCE | 1.21011927 |
| 44 | JAK2 | 1.15986948 |
| 45 | NLK | 1.12569351 |
| 46 | DAPK2 | 1.11585365 |
| 47 | ERBB2 | 1.09556466 |
| 48 | OXSR1 | 1.09364661 |
| 49 | BMPR1B | 1.08489161 |
| 50 | TNIK | 1.06362954 |
| 51 | STK38L | 1.05080135 |
| 52 | EPHA2 | 1.01550025 |
| 53 | KDR | 0.97887778 |
| 54 | CSNK1A1L | 0.97777487 |
| 55 | MAP3K3 | 0.95377500 |
| 56 | JAK1 | 0.93933456 |
| 57 | TBK1 | 0.93265823 |
| 58 | EPHB1 | 0.93177379 |
| 59 | TRPM7 | 0.89242420 |
| 60 | IRAK3 | 0.88410703 |
| 61 | MAP3K14 | 0.87860703 |
| 62 | TLK1 | 0.86103140 |
| 63 | PTK2 | 0.84658644 |
| 64 | STK39 | 0.83795162 |
| 65 | PRKCZ | 0.83236505 |
| 66 | PRKCG | 0.80603401 |
| 67 | EPHA3 | 0.80295124 |
| 68 | PINK1 | 0.79838077 |
| 69 | PTK2B | 0.79003342 |
| 70 | DYRK1B | 0.78748533 |
| 71 | PRKAA1 | 0.78570094 |
| 72 | MAP2K3 | 0.78478216 |
| 73 | MAPK4 | 0.78265040 |
| 74 | PNCK | 0.77605362 |
| 75 | CAMK2D | 0.77559648 |
| 76 | MAP3K2 | 0.76685681 |
| 77 | GSK3A | 0.76568737 |
| 78 | HIPK2 | 0.74111471 |
| 79 | MUSK | 0.73292810 |
| 80 | PRKACG | 0.72019080 |
| 81 | CSNK1A1 | 0.70762657 |
| 82 | CAMK1D | 0.70129944 |
| 83 | CDK6 | 0.69036678 |
| 84 | SGK3 | 0.68772896 |
| 85 | ERBB3 | 0.67977669 |
| 86 | MAPKAPK3 | 0.66131219 |
| 87 | CSK | 0.65661220 |
| 88 | STK16 | 0.65497941 |
| 89 | MAPK13 | 0.62508257 |
| 90 | PLK2 | 0.61628572 |
| 91 | CAMK2G | 0.61567637 |
| 92 | MAP2K2 | 0.61531358 |
| 93 | MAP2K6 | 0.61301701 |
| 94 | FGFR3 | 0.59837254 |
| 95 | TNK2 | 0.59130607 |
| 96 | WNK4 | 0.57778083 |
| 97 | AKT3 | 0.56953867 |
| 98 | CSNK1D | 0.55175498 |
| 99 | NUAK1 | 0.54271525 |
| 100 | MAP3K11 | 0.53095304 |
| 101 | PDPK1 | 0.52840022 |
| 102 | PRKCI | 0.52560481 |
| 103 | MAP3K1 | 0.50898587 |
| 104 | MYLK | 0.50522221 |
| 105 | ADRBK1 | 0.50138335 |
| 106 | MAP2K1 | 0.47463488 |
| 107 | CSNK1E | 0.47293652 |
| 108 | MKNK2 | 0.46939422 |
| 109 | MAP2K7 | 0.46865355 |
| 110 | TIE1 | 0.46471721 |
| 111 | PRKG1 | 0.45746888 |
| 112 | PRKACA | 0.45645702 |
| 113 | PRKG2 | 0.45304949 |
| 114 | SGK1 | 0.45251337 |
| 115 | GRK1 | 0.44816899 |
| 116 | WNK3 | 0.44774570 |
| 117 | IGF1R | 0.44671455 |
| 118 | STK24 | 0.44659235 |
| 119 | SGK2 | 0.44303274 |
| 120 | PRKCQ | 0.44217102 |
| 121 | IKBKB | 0.44197688 |
| 122 | MAPK12 | 0.43598382 |
| 123 | TRIM28 | 0.43582775 |
| 124 | DAPK1 | 0.43081042 |
| 125 | ITK | 0.42581409 |
| 126 | MTOR | 0.42044338 |
| 127 | RPS6KB1 | 0.41794277 |
| 128 | CAMK2A | 0.41192913 |
| 129 | RET | 0.40694212 |
| 130 | STK11 | 0.39976067 |
| 131 | EIF2AK3 | 0.38647158 |
| 132 | MAP3K5 | 0.38219611 |
| 133 | CSNK1G1 | 0.37483909 |
| 134 | IKBKE | 0.37207977 |
| 135 | PAK3 | 0.37095279 |
| 136 | CDK3 | 0.37015450 |
| 137 | SGK494 | 0.36858250 |
| 138 | SGK223 | 0.36858250 |
| 139 | MAPK7 | 0.36064851 |
| 140 | TGFBR2 | 0.35876547 |
| 141 | PRKCH | 0.35497590 |
| 142 | PDGFRA | 0.35480679 |
| 143 | PIK3CA | 0.34803054 |
| 144 | STK3 | 0.33343035 |
| 145 | TXK | 0.33003885 |
| 146 | PRKD2 | 0.32643671 |
| 147 | PDK4 | 0.32591490 |
| 148 | PDK3 | 0.32591490 |
| 149 | EGFR | 0.31694122 |
| 150 | PDK1 | 0.30945799 |
| 151 | ROCK1 | 0.29957320 |
| 152 | CHUK | 0.29941116 |
| 153 | CSF1R | 0.29850655 |
| 154 | PRKCA | 0.28658985 |
| 155 | IRAK1 | 0.28639357 |
| 156 | TAOK1 | 0.28098690 |
| 157 | FER | 0.26786955 |
| 158 | ICK | 0.24881252 |
| 159 | MAP3K13 | 0.24309196 |
| 160 | IRAK2 | 0.23694551 |
| 161 | CAMK1G | 0.22492562 |
| 162 | CDK4 | 0.21552333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.31609755 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.63258677 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39240419 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.19745147 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.96744606 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70735552 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.57217443 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56949990 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54373026 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50011866 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.42647827 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39107270 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28480945 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17913215 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10299475 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.04367425 |
| 17 | Circadian rhythm_Homo sapiens_hsa04710 | 1.94679856 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94065567 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90782506 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.87867248 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86568894 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84638179 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84196626 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83506492 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83287938 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.79425118 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78158058 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74489331 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72045510 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68715537 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67445821 |
| 32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.66363782 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64665957 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61106292 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.60600293 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57690445 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56948624 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.56914257 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.51920096 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50752651 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.49466608 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49335108 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49239174 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.47065719 |
| 45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.43940435 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.42697850 |
| 47 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.39372180 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 1.38317571 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37233139 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34013084 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33223749 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31820453 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.28575453 |
| 54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.26194901 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24563907 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24110671 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20516342 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18977287 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.18817768 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17025396 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14291948 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12769759 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.09250488 |
| 64 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.07217843 |
| 65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06067245 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01474017 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98796635 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98242380 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98138630 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.95084594 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90099416 |
| 72 | Cocaine addiction_Homo sapiens_hsa05030 | 0.86665776 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.85677450 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85133210 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83589106 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.81755178 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79356668 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79335732 |
| 79 | Nicotine addiction_Homo sapiens_hsa05033 | 0.78616943 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78028841 |
| 81 | GABAergic synapse_Homo sapiens_hsa04727 | 0.76117245 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74134067 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73911019 |
| 84 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.72313184 |
| 85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.71479546 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70382092 |
| 87 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.68490769 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.66289569 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65541688 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64035834 |
| 91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59305878 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56822260 |
| 93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52230817 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51465672 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48600324 |
| 96 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.46419537 |
| 97 | Basal transcription factors_Homo sapiens_hsa03022 | 0.46074321 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45497987 |
| 99 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45431634 |
| 100 | Morphine addiction_Homo sapiens_hsa05032 | 0.45073464 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43275461 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39771425 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37234066 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.31694814 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28973147 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.27131821 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21560250 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21198997 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19143852 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17813686 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14344174 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11844578 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08743822 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03950296 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02990156 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | 0.00917078 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2121966 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2089795 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | -0.1948278 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1782562 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1595760 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1557079 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | -0.1503007 |
| 124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1469847 |
| 125 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1346737 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1303058 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1104876 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1019001 |
| 129 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0925166 |
| 130 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0894370 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0856200 |
| 132 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0537023 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0523866 |

